International Journal of Molecular Sciences, Volume 25, Issue 16
2024 August-2 - 579 articles
Cover Story: This review discusses advancements in antibody–drug conjugates (ADCs) with metal-based and nature-inspired payloads, focusing on synthetic strategies for antibody conjugation. Traditional methods like maleimide and succinimide conjugation are widely used, but emerging techniques, such as photoconjugation, offer milder conditions and better selectivity. ADCs enhance cancer treatment by combining monoclonal antibodies’ specificity with chemotherapy drugs’ cytotoxicity, resulting in targeted cancer cell elimination with reduced side effects. Future advancements include improved linker technology, novel cytotoxic agents, and integration with other therapies, making ADCs pivotal in modern medicine. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.